Contributions should be sent to the email address: email@example.com
Editors of the Journal of Metallomics and Nanotechnologies
Types of Publications
JMN has no restrictions on the length of manuscripts, provided that the text is concise and comprehensive. Full experimental details must be provided so that the results can be reproduced by other groups. JMN encourages authors to publish all experimental controls and full datasets as supplementary files (please read the guidelines about Supplementary Materials carefully and references to unpublished data).
The different types of articles published in JMN are indicated in the first section of the Aims & Scope. The main types are: Articles: research manuscripts report new evidence or new conclusions which have neither been published before nor are under consideration for publication in another journal. LMN considers all original research manuscripts provided that the work reports scientifically sound experiments and provides a substantial amount of new information. We strongly recommend authors not to unnecessarily divide their work into several related manuscripts. Short communications of preliminary, but significant, results will also be considered.
Reviews: review manuscripts provide concise and precise updates on the latest progress made in a given area of research.
Conference Papers: Expanded and high quality conference papers are also considered in JMN if they fulfill the following requirements: (1) the paper should be expanded to the size of a research article; (2) the conference paper should be cited and noted on the first page of the paper; (3) if the authors do not hold the copyright to the published conference paper, authors should seek the appropriate permission from the copyright holder; (4) authors are asked to disclose that it is conference paper in their cover letter and include a statement on what has been changed compared to the original conference paper.
Manuscripts for JMN should be submitted online at http://web2.mendelu.cz/af_239_nanotech/J_Met_Nano/index.html. The submitting author, who is generally the corresponding author, is responsible for the manuscript during the submission and peer-review process. The submitting authors must ensure that all co-authors have been included in the author list (read the criteria to qualify for authorship) and that they all have read and approved the submitted version of the manuscript
Authors must use the Microsoft Word template to prepare their manuscript. Using the template file will substantially shorten the time to complete copy-editing and publication of accepted manuscripts. Accepted file formats are: Microsoft Word: Manuscripts prepared in Microsoft Word must be converted into a single file before submission. When preparing manuscripts in Microsoft Word, the JMN Microsoft Word template file must be used. Please insert your graphics (schemes, figures, etc.) in the main text after the paragraph of its first citation.
Research manuscripts should comprise:
Review manuscripts should comprise the front matter, literature review sections and the back matter. The template file can also be used to prepare the front and back matter of your review manuscript. It is not necessary to follow the remaining structure.
Abbreviations should be defined in parentheses the first time they appear in the abstract, main text and in figure captions.
SI Units (International System of Units) should be used for this journal. Imperial, US customary and other units should be converted to SI units whenever possible before submission of a manuscript to the journal.
Accession numbers of RNA, DNA and protein sequences used in the manuscript should be provided in the Materials and Methods section. Please also read the Guidelines for Deposition of Sequences and of Expression Data
Equations: If you are using Word, please use either the Microsoft Equation Editor or the MathType add-on in your paper. Equations should be editable by the editorial office and not appear in a picture format.
These sections should appear in all manuscript types
Title: The title of your manuscript should be concise, specific and relevant. When gene or protein names are included, the abbreviated name rather than full name should be used. Authors List and Affiliations: Authors' full first and last names must be provided. The initials of any middle names can be added. The PubMed/MEDLINE standard format is used for affiliations: complete address information including city, zip code, state/province, country, and all email addresses. At least one author should be designated as corresponding author, and his or her email address and other details should be included at the end of the affiliation section. Please read the criteria to qualify for authorship.
Abstract: The abstract should be a total of about 200 words maximum. The abstract should be a single paragraph and should follow the style of structured abstracts, but without headings: 1) Background: Place the question addressed in a broad context and highlight the purpose of the study; 2) Methods: Describe briefly the main methods or treatments applied; 3) Results: Summarize the article's main findings; and 4) Conclusion: Indicate the main conclusions or interpretations. The abstract should be an objective representation of the article: it must not contain results which are not presented and substantiated in the main text and should not exaggerate the main conclusions.
Keywords: Three to ten pertinent keywords need to be added after the abstract. We recommend that the keywords are specific to the article, yet reasonably common within the subject discipline.
Introduction: The introduction should briefly place the study in a broad context and highlight why it is important. It should define the purpose of the work and its significance. The current state of the research field should be reviewed carefully and key publications should be cited. Please highlight controversial and diverging hypotheses when necessary. Finally, briefly mention the main aim of the work and highlight the main conclusions. As far as possible, please keep the introduction comprehensible to scientists outside your particular field of research.
Results: This section may be divided by subheadings. It should provide a concise and precise description of the experimental results, their interpretation as well as the experimental conclusions that can be drawn.
Discussion: This section may be divided by subheadings. Authors should discuss the results and how they can be interpreted in perspective of previous studies and of the working hypotheses. The findings and their implications should be discussed in the broadest context possible. Future research directions may also be highlighted
. Conclusions: This section is not mandatory, but can be added to the manuscript if the discussion is unusually long or complex.
Materials and Methods: This section should be divided by subheadings. Materials and Methods should be described with sufficient details to allow others to replicate and build on published results. Please note that publication of your manuscript implicates that you must make all materials, data, and protocols associated with the publication available to readers. Please disclose at the submission stage any restrictions on the availability of materials or information. New methods and protocols should be described in detail while well-established methods can be briefly described and appropriately cited.
Research manuscripts reporting large datasets that are deposited in a publicly available database should specify where the data have been deposited and provide the relevant accession numbers. If the accession numbers have not yet been obtained at the time of submission, please state that they will be provided during review. They must be provided prior to publication.
Research manuscripts using human or animal subjects, tissues, field samples or cell lines must include research ethics statements. Please read the Ethical Research Guidelines. Supplementary Materials: This section should be included when supplementary information is published online alongside the manuscript. Please indicate the name and title of each supplementary file as follows Figure S1: title, Table S1: title, etc.
Conflicts of Interest: Authors must identify and declare any personal circumstances or interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results. If there is no conflict of interest, please state "The authors declare no conflict of interest." Any role of the funding sponsors in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript, or in the decision to publish the results must be declared in this section. If there is no role, please state “The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results”.
References: References must be numbered in order of appearance in the text (including tables and legends) and listed individually at the end of the manuscript. We recommend preparing the references with a bibliography software package, such as EndNote, ReferenceManager or Zotero to avoid typing mistakes and duplicated references.
Citations and References in Supplementary files are permitted provided that they also appear in the main text and in the reference list.
Preparing Figures, Schemes and Tables
• All figure files should be separately uploaded during submission.
• Figures and schemes must be provided at a sufficiently high resolution (minimum 1000 pixels width/height, or a resolution of 300 dpi or higher). All Figure file formats are accepted. However, TIFF, JPEG, EPS and PDF files are preferred.
• All Figures, Schemes and Tables should also be inserted into the main text close to their first citation and must be numbered following their number of appearance (Figure 1, Scheme I, Figure 2, Scheme II, Table 1, etc.).
• All Figures, Schemes and Tables should have a short explanatory title and a caption placed above it.
• All table columns should have an explanatory heading. To facilitate the copy-editing of larger tables, smaller fonts may be used, but in no less than 8 pt. in size. Authors should use the Table option of Microsoft Word to create tables.
• For multi-panel figures, the file must contain all data in one file. For tips on creating multi-panel figures, please read the helpful advice provided by L2 Molecule.
• Authors are encouraged to prepare figures and schemes in color (RGB at 8-bit per channel). Full color graphics will be published free of charge.
Authorship must include and be strictly limited to researchers who have substantially contributed to the reported work. To qualify for authorship, a researcher should have made a substantial contribution to the design of the study, or to the production, analysis or interpretation of the results. Authors should also have been involved in the preparation and have approved the submitted manuscript. Those who contributed to the work but do not qualify for authorship should be listed in the acknowledgments. According to the Committee on Publication Ethics (COPE) standard, to which this journal adheres, "all authors should agree to be listed and should approve the submitted and accepted versions of the publication. Any change to the author list should be approved by all authors including any who have been removed from the list. The corresponding author should act as a point of contact between the editor and the other authors and should keep co-authors informed and involve them in major decisions about the publication (e.g. answering reviewers’ comments)." 
It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflict of interest". This should be conveyed in a separate "Conflicts of Interest" section preceding the "References" sections at the end of the manuscript. Financial support for the study must be fully disclosed in the "Acknowledgments" section.
All submitted manuscripts received by the Editorial Office will be checked by a professional in-house Managing Editor to determine whether it is properly prepared and whether the manuscript follows the ethical policies of the journal, including those for human and animal experimentation. Manuscripts that do not fit the journal or are not in line with our ethical policy may be rejected before peer-review. Manuscripts that are not properly prepared will be returned to the authors for revision and resubmission. The Managing Editor will consult the journals’ Editor-in-Chief, the Guest Editor or an Editorial Board member to determine whether the manuscript fits the scope of the journal and whether it is scientifically sound. No judgment on the significance or potential impact of the work will be made at this stage.
Once a manuscript passes the initial checks, it will be assigned to at least two independent experts for peer-review. A single-blind peer-review process is applied, where authors' names are revealed to reviewers. In-house assistant editors generally invite experts recommended by the Editor-in-Chief or identified by literature searches. These experts may also include Editorial Board members and Guest Editors of the journal. Potential reviewers suggested by the authors may also be considered. Reviewers should not have published with any of the co-authors during the past five years and should not currently work or collaborate with one of the institutes of the co-authors of the submitted manuscript.
Editorial Decision and Revision
Based on the comments and advices of the peer-reviewers, an external editor – usually the Editor-in-Chief or a Guest Editor – will make a decision to accept, reject, or to ask authors to revise the manuscript.
For Minor Revisions the authors will have one week to resubmit their revised manuscript. For Major Revisions the authors will have two weeks to resubmit their revised manuscript. However, authors should contact the editorial office if extended revision time is anticipated.
Authors may appeal a rejection by sending an e-mail to the Editorial Office of the journal. The appeal must provide a detailed justification, including point-by-point responses to the reviewers' and/or Editor's comments. The Managing Editor of the journal will forward the manuscript and relating information (including the identities of the referees) to an Editorial Board member who was not involved in the initial decision-making process. If no appropriate Editorial Board member is available, the editor will identify a suitable external scientist. The Editorial Board member will be asked to give an advisory recommendation on the manuscript and may recommend acceptance, further peer-review, or uphold the original rejection decision. A reject decision at this stage will be final and cannot be revoked.
Production and Publication
Once accepted, the manuscript will undergo professional copy-editing, English editing, proofreading by the authors, final corrections, pagination, and, publication on the http://web2.mendelu.cz/af_239_nanotech/J_Met_Nano/ website.
During the submission process, authors have the possibility to suggest potential reviewers with the appropriate expertise to review the manuscript. The editors will not necessarily approach these referees. Please provide detailed contact information (address, homepage, phone, e-mail address). The proposed referees should neither be current collaborators of the co-authors nor have published with any of the co-authors of the manuscript within the last five years. Proposed reviewers should be from different institutions to the authors. You may identify appropriate Editorial Board members of the journal as potential reviewers. You may also suggest reviewers from among the authors that you frequently cite in your paper.
This journal is published in English. To facilitate proper peer-reviewing of your manuscript, it is essential that it is submitted in grammatically correct English. If you are not a native English speaker, we strongly recommend that you have your manuscript professionally edited before submission or read by a native English-speaking colleague. Professional editing will mean that reviewers and future readers are better able to read and assess the content of your manuscript. For additional information see the English Editing Guidelines for Authors.
The editors of this journal take the responsibility to enforce a rigorous peer-review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The editors of JMN take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy.
Our in-house editors will investigate any allegations of publication misconduct and may contact the authors' institutions or funders if necessary. If evidence of misconduct is found, appropriate action will be taken to correct or retract the publication. Authors are expected to comply with the best ethical publication practices when publishing with LMN.
New sequence information must be deposited to the appropriate database prior to submission of the manuscript. Accession numbers provided by the database should be included in the submitted manuscript. Manuscripts will not be published until the accession number is provided.
All sequence names and the accession numbers provided by the databases should be provided in the Materials and Methods section of the article.
The editors will require that the benefits potentially derived from any research causing harm to animals are significant in relation to any cost endured by animals, and that procedures followed are unlikely to cause offense to the majority of readers. Authors should particularly ensure that their research complies with the commonly-accepted '3Rs':
Any experimental work must also have been conducted in accordance with relevant national legislation on the use of animals for research. For further guidance authors should refer to the Code of Practice for the Housing and Care of Animals Used in Scientific Procedures .
Open Access content means the content is free of cost, and no restrictions are applied on its Licensing and Copyrights. Open Access Journals provide free of charge scholarly content. The literature is available for reading, downloading, and editing. The benefit of open access is that the content can be reused for a novel cause/research/experiment.
Toto dílo podléhá licenci Creative Commons Uveďte autora-Neužívejte dílo komerčně-Nezasahujte do díla 4.0 Mezinárodní License.